MHY-1685

CAS No. 27406-31-1

MHY-1685( 5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione )

Catalog No. M28290 CAS No. 27406-31-1

MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
25MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MHY-1685
  • Note
    Research use only, not for human use.
  • Brief Description
    MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
  • Description
    MHY-1685 is a mammalian target of rapamycin (mTOR) inhibitor and a senescence inhibitor that can rejuvenate senile hCSCs by modulating autophagy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    27406-31-1
  • Formula Weight
    232.195
  • Molecular Formula
    C11H8N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (269.18 mM)
  • SMILES
    Oc1ccc(C=C2C(=O)NC(=O)NC2=O)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Sánchez-Hernández E, et al. Physicochemical Characterization and Antimicrobial Activity against Erwinia amylovora, Erwinia vitivora, and Diplodia seriata of a Light Purple Hibiscus syriacus L. Cultivar. Plants (Basel). 2021 Sep 10;10(9):1876.
molnova catalog
related products
  • JR-AB2-011

    JR-AB2-011 inhibits mTORC2 activity by blocking Rictor-mTOR association (Ki: 0.19 μM). JR-AB2-011 has anti-glioblastoma multiforme (GBM) properties.

  • mTOR inhibitor 9b

    mTOR inhibitor 9b is an enzyme inhibitor of protein kinase mTOR he phosphatidylinositol 3-kinase PIK3CA with IC50s of 0.76 nm and 1.262 μM, respectively.

  • Tretazicar

    CB1954(Tretazicar), an anticancer prodrug, is activated by NAD(P)H quinone oxidoreductase 2.